Mark Emalfarb

Dyadic Announces Nonexclusive Research License with WuXi Biologics

New Delhi, March 30, 2020: Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving…

5 years ago